# Top 50 Antibodies Startups Worldwide by Funding (2026)

> The 50 best-funded antibodies startups worldwide, ranked by total funding raised: $3.3B combined. With founding year, headquarters and each company's rounds.

Source: https://millionrounds.com/top-lists/antibodies-startups (Millionrounds; every figure on the page links to its filing or article)

- 1 [**NovImmune** NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders.](https://millionrounds.com/company/novimmune) NovImmmune develops therapeutic monoclonal antibodies to treat patients suffering from immune-related disorders. *Founded* 1998 Plan-les-Ouates, Switzerland **$352M** last round Feb 2014
- 2 [**Atreca** Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.](https://millionrounds.com/company/atreca) Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen. *Founded* 2010 United States **$313M** last round Jul 2020
- 3 [**Allakos** Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.](https://millionrounds.com/company/allakos) Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases. *Founded* 2012 Redwood City, United States **$294M** last round Sept 2022
- 4 [**Alentis Therapeutics** Alentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland.](https://millionrounds.com/company/alentis-therapeutics) Alentis Therapeutics is a clinical-stage biotechnology company based in Basel, Switzerland. *Founded* 2019 Allschwil, Switzerland **$194M** last round Nov 2024
- 5 [**VectorY** VectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020.](https://millionrounds.com/company/vectory) VectorY Therapeutics is an Amsterdam-based biotechnology company founded in August 2020. *Founded* 2020 Amsterdam, Netherlands **$138M** last round Nov 2023
- 6 [**Innate Pharma** Innate Pharma S.A.](https://millionrounds.com/company/innate-pharma) Innate Pharma S.A. *Founded* 1999 Marseille, France **$134M** last round Jun 2014
- 7 [**Diagonal Therapeutics** Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases.](https://millionrounds.com/company/diagonal-therapeutics) Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe genetic diseases. *Founded* 2022 Watertown, United States **$125M** last round Jan 2026
- 8 [**Invivyd** Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.](https://millionrounds.com/company/invivyd) Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections. *Founded* 2020 Waltham, United States **$125M** last round Nov 2025
- 9 [**Merida Biosciences** Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autoimmune and allergic diseases.](https://millionrounds.com/company/merida-biosciences) Merida Biosciences is a biotechnology company based in Cambridge, Massachusetts, focused on developing precision medicines for autoimmune and allergic diseases. *Founded* 2022 Cambridge, United States **$121M** last round Apr 2025
- 10 [**AgomAB Therapeutics** AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.](https://millionrounds.com/company/agomab-therapeutics) AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues. *Founded* 2017 Antwerpen, Belgium **$112M** last round Oct 2024
- 11 [**Bambusa Therapeutics** Bambusa Therapeutics is a biotechnology company based in Boston's Seaport, founded in May 2024.](https://millionrounds.com/company/bambusa-therapeutics) Bambusa Therapeutics is a biotechnology company based in Boston's Seaport, founded in May 2024. *Founded* 2024 Boston, United States **$90M** last round Nov 2025
- 12 [**Precirix** Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014.](https://millionrounds.com/company/precirix) Precirix is a clinical-stage biotechnology company based in Brussels, Belgium, founded in 2014. *Founded* 2014 Jette, Belgium **$88M** last round Mar 2022
- 13 [**varnotech** Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses.](https://millionrounds.com/company/varnotech) Varnotech specializes in developing vaccines, antibodies, and adjuvants to combat diseases and viruses. *Founded* 2019 China **$83M** last round Mar 2024
- 14 [**Adagene** Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.](https://millionrounds.com/company/adagene) Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies. *Founded* 2011 China **$83M** last round Jul 2025
- 15 [**Ra Pharmaceuticals** Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules.](https://millionrounds.com/company/ra-pharmaceuticals) Ra Pharma is developing Cyclomimetics, a new drug class combining the properties and benefits of antibodies and small molecules. *Founded* 2008 United States **$77M** last round Jul 2015
- 16 [**LigoCyte Pharmaceuticals** LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.](https://millionrounds.com/company/ligocyte-pharmaceuticals) LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications. *Founded* 1998 United States **$72M** last round Jun 2012
- 17 [**SciRhom** SciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016.](https://millionrounds.com/company/scirhom) SciRhom GmbH is a biotechnology company based in Martinsried, Germany, founded in 2016. *Founded* 2016 Planegg, Germany **$68M** last round Jul 2024
- 18 [**Rondo Therapeutics** Rondo Therapeutics is a clinical-stage biopharmaceutical company based in Hayward, California, focused on developing next-generation T-cell engaging bispecific](https://millionrounds.com/company/rondo-therapeutics) Rondo Therapeutics is a clinical-stage biopharmaceutical company based in Hayward, California, focused on developing next-generation T-cell engaging bispecific *Founded* 2021 Hayward, United States **$67M** last round Mar 2022
- 19 [**VelaVigo** VelaVigo is a biotech company that specializes in the discovery and development of multi-specific antibodies and antibody-drug conjugates (ADCs).](https://millionrounds.com/company/velavigo) VelaVigo is a biotech company that specializes in the discovery and development of multi-specific antibodies and antibody-drug conjugates (ADCs). *Founded* 2021 Shanghai, China **$60M** last round Jul 2025
- 20 [**Rinat Neuroscience** A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat.](https://millionrounds.com/company/rinat-neuroscience) A leader in the development of therapeutic antibodies, spun out its key neuroscience assets under a broad license to Rinat. *Founded* 2000 United States **$58M** last round Aug 2003
- 21 [**Third Arc Bio** Third Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022.](https://millionrounds.com/company/third-arc-bio) Third Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022. *Founded* - Philadelphia, United States **$52M** last round Feb 2026
- 22 [**Metaphore Biotechnologies** Metaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.](https://millionrounds.com/company/metaphore-biotechnologies) Metaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering. *Founded* 2021 Cambridge, United States **$50M** last round Apr 2026
- 23 [**Cytovance Biologics** Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations.](https://millionrounds.com/company/cytovance-biologics) Cytovance Biologics produces therapeutic proteins and antibodies from mammalian cell cultures and microbial fermentations. *Founded* 2005 Oklahoma City, United States **$43M** last round Oct 2014
- 24 [**ImaginAb** ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.](https://millionrounds.com/company/imaginab) ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins. *Founded* 2007 Inglewood, United States **$42M** last round Oct 2017
- 25 [**Adimab** Adimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies.](https://millionrounds.com/company/adimab) Adimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies. *Founded* 2007 Lebanon, United States **$40M** last round Apr 2012
- 26 [**Xencor** Proteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer.](https://millionrounds.com/company/xencor) Proteins by Design Antibody and protein biotherapeutics are changing the way physicians treat autoimmune diseases, asthma, and cancer. *Founded* 1997 Pasadena, United States **$36M** last round Jul 2013
- 27 [**Excelimmune** Excelimmune is a biopharmaceutical company developing fully human recombinant polyclonal antibodies for therapeutics.](https://millionrounds.com/company/excelimmune) Excelimmune is a biopharmaceutical company developing fully human recombinant polyclonal antibodies for therapeutics. *Founded* 2006 Lexington, United States **$34M** last round Jan 2012
- 28 [**Sorriso Pharmaceuticals** Sorriso Pharmaceuticals is a private biopharmaceutical company founded in 2020, based in Sandy, Utah.](https://millionrounds.com/company/sorriso-pharmaceuticals) Sorriso Pharmaceuticals is a private biopharmaceutical company founded in 2020, based in Sandy, Utah. *Founded* 2020 San Diego, United States **$31M** last round Dec 2021
- 29 [**Kanova** Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases.](https://millionrounds.com/company/kanova) Kanova is a biopharmaceutical firm that focuses on developing therapeutic antibodies to treat cancer and autoimmune diseases. *Founded* 2015 China **$30M** last round Jul 2023
- 30 [**SparX Group** SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates.](https://millionrounds.com/company/sparx-group) SparX Group is a biotech firm that develops innovative anticancer biologics through bispecific antibodies and drug conjugates. *Founded* 2021 Grand Cayman, Cayman Islands **$30M** last round Dec 2021
- 31 [**Galux** Galux is a biotechnology company based in Seoul, South Korea, founded in 2020.](https://millionrounds.com/company/galux) Galux is a biotechnology company based in Seoul, South Korea, founded in 2020. *Founded* 2020 South Korea **$29M** last round Feb 2026
- 32 [**April Bio** April Bio is a drug development company that develops antibodies and long-acting biologics.](https://millionrounds.com/company/april-bio) April Bio is a drug development company that develops antibodies and long-acting biologics. *Founded* 2013 Chuncheon **$22M** last round Aug 2021
- 33 [**Protillion Biosciences** Protillion Biosciences is a biotechnology company based in Carlsbad, California, focused on discovering and optimizing therapeutic antibodies and protein-based drugs.](https://millionrounds.com/company/protillion-biosciences) Protillion Biosciences is a biotechnology company based in Carlsbad, California, focused on discovering and optimizing therapeutic antibodies and protein-based drugs. *Founded* 2019 Carlsbad, United States **$18M** last round Dec 2022
- 34 [**Capella BioScience** Capella Bioscience engages in the discovery and development of monoclonal antibodies.](https://millionrounds.com/company/capella-bioscience) Capella Bioscience engages in the discovery and development of monoclonal antibodies. *Founded* 2014 United Kingdom **$16M** last round Mar 2016
- 35 [**CEVEC Pharmaceuticals** CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns.](https://millionrounds.com/company/cevec-pharmaceuticals) CEVEC Pharmaceuticals develops therapeutic proteins and monoclonal antibodies with human glycosylation patterns. *Founded* 2003 Germany **$14M** last round Jul 2011
- 36 [**Antiverse** Antiverse is a techbio company based in Cardiff, UK, with an office in Boston, MA.](https://millionrounds.com/company/antiverse) Antiverse is a techbio company based in Cardiff, UK, with an office in Boston, MA. *Founded* 2017 Rhoose, United Kingdom **$14M** last round Jun 2026
- 37 [**Zumutor Biologics** Zumutor Biologics is a clinical-stage immuno-oncology company founded in 2013, focused on developing first-in-class monoclonal antibodies that target Natural Ki](https://millionrounds.com/company/zumutor-biologics) Zumutor Biologics is a clinical-stage immuno-oncology company founded in 2013, focused on developing first-in-class monoclonal antibodies that target Natural Ki *Founded* 2015 Cambridge, United States **$14M** last round Jun 2026
- 38 [**Animab** Animab is a Belgian biotechnology company founded in 2020, focused on developing orally administered monoclonal antibodies to protect livestock from gastrointes](https://millionrounds.com/company/animab) Animab is a Belgian biotechnology company founded in 2020, focused on developing orally administered monoclonal antibodies to protect livestock from gastrointes *Founded* 2020 Ghent, Belgium **$12M** last round Jul 2025
- 39 [**Kenta Biotech** Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections.](https://millionrounds.com/company/kenta-biotech) Kenta Biotech discovers and develops monoclonal antibodies for the treatment of serious bacterial and viral infections. *Founded* 2006 Switzerland **$10M** last round Mar 2009
- 40 [**Aptitude Medical Systems** Aptitude Medical Systems focuses on the potential of aptamers to solve the fundamental problems of antibodies.](https://millionrounds.com/company/aptitude-medical-systems) Aptitude Medical Systems focuses on the potential of aptamers to solve the fundamental problems of antibodies. *Founded* 2011 Minneapolis, United States **$10M** last round Jul 2025
- 41 [**DJS Antibodies** DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs.](https://millionrounds.com/company/djs-antibodies) DJS Antibodies designs and discovers novel therapeutic monoclonal antibodies against GPCRs. *Founded* 2014 Headington **$8.0M** last round Dec 2020
- 42 [**Genesis Biopharma** Genesis Biopharma – your top source for biotech and pharma needs.](https://millionrounds.com/company/genesis-biopharma) Genesis Biopharma – your top source for biotech and pharma needs. *Founded* 2023 United States **$7.7M** last round Jun 2013
- 43 [**Affomix Corporation** Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies.](https://millionrounds.com/company/affomix-corporation) Affomix develops technology for the automated, high-throughput selection of human monoclonal antibodies. *Founded* 2006 United States **$7.0M** last round Feb 2008
- 44 [**Cantai Therapeutics** Cantai Therapeutics is a biotechnology company dedicated to developing bispecific antibodies aimed at treating autoimmune and inflammatory diseases.](https://millionrounds.com/company/cantai-therapeutics) Cantai Therapeutics is a biotechnology company dedicated to developing bispecific antibodies aimed at treating autoimmune and inflammatory diseases. *Founded* 2023 Philadelphia, United States **$6.5M** last round Jan 2026
- 45 [**BioGenes Technologies** Biogenes Technologies is a Malaysian biotechnology startup founded in 2015, focused on molecular diagnostics and genomics.](https://millionrounds.com/company/biogenes-technologies) Biogenes Technologies is a Malaysian biotechnology startup founded in 2015, focused on molecular diagnostics and genomics. *Founded* 2015 Kuala Lumpur, Malaysia **$5.7M** last round Jan 2023
- 46 [**DotBio** DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.](https://millionrounds.com/company/dotbio) DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies. *Founded* 2017 Singapore, Singapore **$5.6M** last round Aug 2023
- 47 [**GamaMabs Pharma** GamaMabs Pharma is a French biotechnology company specializing in immuno-oncology and the development of therapeutic monoclonal antibodies for cancer treatment,](https://millionrounds.com/company/gamamabs-pharma) GamaMabs Pharma is a French biotechnology company specializing in immuno-oncology and the development of therapeutic monoclonal antibodies for cancer treatment, *Founded* 2013 Toulouse, France **$4.0M** last round Sept 2013
- 48 [**Orega Biotech** OREGA Biotech is a French biotechnology company founded in 2010, specializing in the discovery and development of first-in-class monoclonal antibodies for cance](https://millionrounds.com/company/orega-biotech) OREGA Biotech is a French biotechnology company founded in 2010, specializing in the discovery and development of first-in-class monoclonal antibodies for cance *Founded* 2010 Ecully, France **$3.7M** last round Sept 2010
- 49 [**Panosome** Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins.](https://millionrounds.com/company/panosome) Panosome is a biotech startup with a novel, proprietary platform to generate antibodies to small molecules, peptides, and proteins. *Founded* - Heidelberg, Germany **$3.4M** last round Jun 2024
- 50 [**Harbour Antibodies** Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies.](https://millionrounds.com/company/harbour-antibodies) Harbour Antibodies uses transgenic mouse technology for engineering mice to produce high affinity human antibodies. *Founded* 2006 Newton, United States **$3.2M** last round Jul 2013

**Total funding** how the list is ranked

**15 November 2026** updated nightly

**Rounds we track** source: Millionrounds

Companies whose own description names this theme, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.

## Who backed them?

Open any company for its rounds and investors, or search the investors who back antibodies startups worldwide in the app, with filters, lists and exports.

[Find their investors](https://millionrounds.com/login?join=1&next=/app/investors)[All top lists](https://millionrounds.com/top-lists)

## More lists worldwide

[See all](https://millionrounds.com/top-lists?r=Global)

[*GV* *V* *RP* **Health startups worldwide** 12,811 companies · $81B](https://millionrounds.com/top-lists/health-startups)[*O* *A* *X* **AI startups worldwide** 10,238 companies · $830B](https://millionrounds.com/top-lists/ai-startups)[*GV* *V* *RP* **Biotech startups worldwide** 7,127 companies · $70B](https://millionrounds.com/top-lists/biotech-startups)[*D* *B* *FT* **Big data startups worldwide** 3,812 companies · $220B](https://millionrounds.com/top-lists/big-data-startups)[*AF* *R* *S* **Fintech startups worldwide** 3,200 companies · $94B](https://millionrounds.com/top-lists/fintech-startups)[*O* *A* *B* **AI startups that raised in 2026** 2,922 companies · $540B in 2026](https://millionrounds.com/top-lists/ai-startups-raised-2026)[*FT* *CE* *P* **Energy providers startups worldwide** 2,808 companies · $152B](https://millionrounds.com/top-lists/energy-providers-startups)[*A* *P* *O* **Marketing tech startups worldwide** 2,728 companies · $28B](https://millionrounds.com/top-lists/marketing-tech-startups)